Patents/Assignees

Nacuity Pharmaceuticals, Inc.

5 patents in portfolio

US12458608utility2025
N-acetylcysteine Amide (NACA) and (2R,2R′)-3,3′ Disulfanediyl Bis(2-acetamidopropanamide) (DINACA) for the Prevention and Treatment of Radiation Dermatitis and Skin Lightening, Skin Whitening and Skin Improvement
0 cites
US12245998utility2025
N-acetylcysteine Amide (NACA) and (2R,2R′)-3,3′ Disulfanediyl Bis(2-acetamidopropanamide) (dinaca) for the Prevention and Treatment of Radiation Pneumonitis and Treatment of Pulmonary Function in Cystic Fibrosis
0 cites
US11766413utility2023
Treatment of Age-related Macular Degeneration, Glaucoma, and Diabetic Retinopathy with N-acetylcysteine Amide (NACA) or (2r,2r′)-3,3′-disulfanediyl Bis(2-acetamidopropanamide)(dinaca)
0 cites
US11753370utility2023
Methods of Making Deuterium-enriched N-acetylcysteine Amide (d-naca) and (2R, 2r′)-3,3′-disulfanediyl Bis(2-acetamidopropanamide) (dinaca) and Using D-naca and Dinaca to Treat Diseases Involving Oxidative Stress
0 cites
US11548851utility2023
Method for Preparation of N-acetyl Cysteine Amide and Derivatives Thereof
0 cites